Earnings release
Page 1
NovoSorbⓇ BTM 12 January 2021 ASX Announcement Interim Trading Update PolyNovo PolyNovo Limited ABN 96 083 866 862 2/320 Lorimer Street Port Melbourne VIC Australia 3207 P +61 ( 0 ) 3 8681 4050 F +61 ( 0 ) 3 8681 4099 • H1 FY21 up 31 % on H1 FY20 . Strong sales Q1 FY21 up 75 % on Q1 FY20 • Slower than expected sales in October and November • Strong December sales exceeded budget in US , NZ , and Taiwan New Accounts - Direct Markets - · H1 FY21 opened 35 new accounts across all direct markets - CY20 opened 109 new accounts representing 89 % growth on CY19 - Strong platform growth during a pandemic evident by significant account acquisition United States - Q1 FY21 up 70 % on Q1 FY20 - Q2 FY21 up 16 % on Q2 FY20 -1H FY21 up 41 % on 1H FY21 - Sales for the month of December 2020 exceeded budget - Hired 12 experienced and dedicated Territory Managers and 1 Sales Director in 1H FY21 Received more Requests for Proposal ( RFP ) in last 3 months than previous 9 months - Signed two GPOs and a number of large strategic hospitals - Ongoing progress with GPO's but has slowed due to COVID - 19 , however we expect to see movement in Q3 FY21 - Participated in a few large IDN RFP's and anticipate agreements in place in Q3 FY21 - Expanded our military presence with the addition of Portsmouth Naval - Added a second account in Canada that has used BTM for a challenging case through the Health Canada Special Access Program - Webinars and virtual conferences are driving new accounts - Recruiting additional sales staff so further growth expected from new geographics Other Countries - First sale to Taiwan in December and executed sales to Singapore , Finland and South Africa - New Zealand and Taiwan sales for the month of December 2020 exceeded budget - Entered new markets Greece , Belgium , Netherlands , Luxembourg , Sweden , Finland , and Taiwan - Our DACH / Benelux distributor has clinical evaluations in 30 new accounts underway - UK is building on its customer base with 6 clinical evaluations underway - First clinical evaluation performed in Ireland Improving outcomes . Changing lives .